Neuroimaging in drug and substance abuse part I: Cocaine, cannabis, and ecstasy

Topics in Magnetic Resonance Imaging

Volumn 16, Issue 3, 2005, Pages 231-238

  Rojas, Rafael ^a   Riascos, Roy ^b   Vargas, Daniel ^b   Cuellar, Hugo ^b   Borne, Jessica ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Atrophy; Brain; Cocaine; Drug abuse; Ecstasy; Imaging; Marijuana; MRI; Stroke

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ADRENALIN; CANNABINOID RECEPTOR; CANNABIS; CATECHOLAMINE; COCAINE; DRONABINOL; G PROTEIN COUPLED RECEPTOR; ILLICIT DRUG; NORADRENALIN;

BRAIN ATROPHY; BRAIN BLOOD FLOW; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN SIZE; BRAIN VASCULITIS; CANNABIS ADDICTION; CEREBROVASCULAR ACCIDENT; CIGARETTE SMOKING; COCAINE DEPENDENCE; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL MALFORMATION; DOPPLER ECHOGRAPHY; DRUG ABUSE; HEMODYNAMIC MONITORING; HUMAN; LONG TERM EXPOSURE; MAGNETIC RESONANCE ANGIOGRAPHY; NEUROIMAGING; NEUROTOXICITY; ORTHOSTATIC HYPOTENSION; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; STROKE; SUBSTANCE ABUSE;

ATROPHY; CENTRAL NERVOUS SYSTEM DISEASES; COCAINE-RELATED DISORDERS; FEMALE; HALLUCINOGENS; HUMANS; MAGNETIC RESONANCE IMAGING; MARIJUANA ABUSE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PREGNANCY; STREET DRUGS;

EID: 33644842104     PISSN: 08993459     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rmr.0000192156.46492.24     Document Type: Review

References (75)

1. Brown E, Prager J, Lee HY, et al. CNS complications of cocaine abuse: prevalence, pathophysiology, and neuroradiology. AJR Am J Roentgenol. 1992;159:137-147.
2. Bartzokis G, Beckson M, Hance DB, et al. Magnetic resonance imaging evidence of "silent" cerebrovascular toxicity in cocaine dependence. Biol Psychiatry. 1999;45:1203-1211.
3. Fessler RD, Esshaki EM, Stankewitz RC, et al. The neurovascular complications of cocaine. Surg Neurol. 1997;47:339-345.
4. Cregler LL, Mark H. Medical complications of cocaine abuse. N Engl J Med. 1986;315:1495-1500.
5. Nolte KB, Brass LM, Fletterick CF. Intracranial hemorrhage associated with cocaine abuse: a prospective autopsy study. Neurology. 1996;46:1291-1296.
6. Goodman LS, Gilman A, Gilman AG. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 7th ed. 1985, New York: Macmillan; xvi:1839.
7. Daras M, Tuchman AJ, Koppel BS, et al. Neurovascular complications of cocaine. Acta Neurol Scand. 1994;90:124-129.
8. Levine SR, Brust JC, Futrell N, et al. Cerebrovascular complications of the use of the "crack" form of alkaloidal cocaine. N Engl J Med. 1990;323:699-704.
9. Jacobs IG, Roszler MH, Kelly JK, et al. Cocaine abuse: neurovascular complications. Radiology. 1989;170:223-227.
10. Klonoff DC, Andrews BT, Obana WG. Stroke associated with cocaine use. Arch Neurol. 1989;46:989-993.
11. Lyoo IK, Streeter CC, Ahn KH, et al. White matter hyperintensities in subjects with cocaine and opiate dependence and healthy comparison subjects. Psychiatry Res. 2004;131:135-145.
12. Mody CK, Miller BL, McIntyre HB, et al. Neurologic complications of cocaine abuse. Neurology. 1988;38:1189-1193.
13. Konzen JP, Levine SR, Garcia JH. Vasospasm and thrombus formation as possible mechanisms of stroke related to alkaloidal cocaine. Stroke. 1995;26:1114-1118.
14. Dackis CA, Dackis MA, Martin D, et al. Platelet serotonin transporter in cocaine patients. NIDA Res Monogr. 1984;55:164-169.
15. Edvinsson L, MacKenzie ET. Amine mechanisms in the cerebral circulation. Pharmacol Rev. 1976;28:275-348.
16. Kelly P, Philip SJ, Ritchie IO. Acute cocaine alters cerebrovascular aurorregulation in the rat neocortex. Brain Res Bull. 1993;31:581-585.
17. Caplan L. Intracerebral hemorrhage revisited. Neurology. 1988;38:624-627.
18. Huang QF, Gebrewold A, Altura BT, et al. Cocaine-induced cerebral vascular damage can be ameliorated by Mg2+ in rat brain. Neurosci Lett. 1990;109:113-116.
19. Lin Y, Leskawa KC. Cytotoxicity of the cocaine metabolite benzoylecgonine. Brain Res. 1994;643:108-114.
20. Madden JA, Konkol RJ, Keller PA, et al. Cocaine and benzoylecgonine constrict cerebral arteries by different mechanisms. Life Sci. 1995;56:679-686.
21. Togna G, Tempesta E, Togna AR, et al. Platelet responsiveness and biosynthesis of thromboxane and prostacyclin in response to in vitro cocaine treatment. Haemostasis. 1985;15:100-107.
22. Fayad PB, McDougle CJ, Pavalkis FJ, et al. Acute hemodynamic effects of intranasal cocaine on the cerebral and cardiovascular systems [abstract]. Stroke. 1992;23:159.
23. Sloan MA, Mattioni TA. Concurrent myocardial and cerebral infarctions after intranasal cocaine use. Stroke. 1992;23:427-430.
24. Citron BP, Halpern M, McCarron M, et al. Necrotizing angiitis associated with drug abuse. N Engl J Med. 1970;283:1003-1011.
25. Kaye BR, Fainstat M. Cerebral vasculitis associated with cocaine abuse. JAMA. 1987;258:2104-2106.
26. Krendel DA, Ditter SM, Frankel MR, et al. Biopsy-proven cerebral vasculitis associated with cocaine abuse. Neurology. 1990;40:1092-1094.
27. Chow JM, Robertson AL Jr, Stein RJ. Vascular changes in the nasal submucosa of chronic cocaine addicts. Am J Forensic Med Pathol. 1990;11:136-143.
28. Volkow ND, Mullani N, Gould KL, et al. Cerebral blood flow in chronic cocaine users: a study with positron emission tomography. Br J Psychiatry. 1988;152:641-648.
29. Bolouri MR, Small GA. Neuroimaging of hypoxia and cocaine-induced hippocampal stroke. J Neuroimaging. 2004;14:290-291.
30. Kaufman MJ, Levin JM, Ross MH, et al. Cocaine-induced cerebral vasoconstriction detected in humans with magnetic resonance angiography. JAMA. 1998;279:376-380.
31. Mineura K, Sasajima H, Kikuchi K, et al. White matter hyperintensity in neurologically asymptomatic subjects. Acta Neurol Scand. 1995;92:151-156.
32. Thurnher MM, Castillo M. Imaging in acute stroke. Eur Radiol. 2005;15:408-415.
33. Strickland TL, et al. Cerebral perfusion and neuropsychological consequences of chronic cocaine use. J Neuropsychiatry Clin Neurosci. 1993;5:419-427.
34. Volkow ND, Valentine A, Kulkarni M. Radiological and neurological changes in the drug abuse patient: a study with MRI. J Neuroradiol. 1988;15:288-293.
35. Pascual-Leone A, Dhuna A, Anderson DC. Cerebral atrophy in habitual cocaine abusers: a planimetric CT study. Neurology. 1991;41:34-38.
36. Bartzokis G, et al. Age-related brain volume reductions in amphetamine and cocaine addicts and normal controls: implications for addiction research. Psychiatry Res. 2000;98:93-102.
37. Matochik JA, et al. Frontal cortical tissue composition in abstinent cocaine abusers: a magnetic resonance imaging study. Neuroimage. 2003;19:1095-1102.
38. Heier LA, Carpanzano CR, Mast J, et al. Maternal cocaine abuse: the spectrum of radiologic abnormalities in the neonatal CNS. AJNR Am J Neuroradiol. 1991;12:951-956.
39. Woods JR Jr, Plessinger MA, Clark KE. Effect of cocaine on uterine blood flow and fetal oxygenation. JAMA. 1987;257:957-961.
40. Hoyme HE, Jones KL, Dixon SD, et al. Prenatal cocaine exposure and fetal vascular disruption. Pediatrics. 1990;85:743-747.
41. Van Allen MI. Fetal vascular disruptions: mechanisms and some resulting birth defects. Pediatr Ann. 1981;10:219-233.
42. Bingol N, Fuchs M, Diaz V, et al. Teratogenicity of cocaine in humans. J Pediatr. 1987;110:93-96.
43. Chasnoff IJ, Burns WJ, Schnell SH, et al. Cocaine use in pregnancy. N Engl J Med. 1985;313:666-669.
44. MacGregor SN, Keith LG, Chasnoff IJ, et al. Cocaine use during pregnancy: adverse perinatal outcome. Am J Obstet Gynecol. 1987;157:686-690.
45. Oro AS, Dixon SD. Perinatal cocaine and methamphetamine exposure: maternal and neonatal correlates. J Pediatr. 1987;111:571-578.
46. Chasnoff IJ, Chisum GM, Kaplan WE. Maternal cocaine use and genitourinary tract malformations. Teratology. 1988;37:201-204.
47. Moussouttas M. Cannabis use and cerebrovascular disease. Neurologist. 2004;10:47-53.
48. Howlett AC, et al. Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology. 2004;47(suppl 1):345-358.
49. Iversen L. Cannabis and the brain. Brain. 2003;126:1252-1270.
50. Mateo I, Pinedo A, Gomez-Beldarrain M, et al. Recurrent stroke associated with cannabis use. J Neurol Neurosurg Psychiatry. 2005;76:435-437.
51. Benowitz NL, Rosenberg J, Rogers W, et al. Cardiovascular effects of intravenous delta-9-tetrahydrocannabinol: autonomic nervous mechanisms. Clin Pharmacol Ther. 1979;25:440-446.
52. Jones RT. Cardiovascular system effects of marijuana. J Clin Pharmacol. 2002;42(11 suppl):58S-63S.
53. Finsterer J, Christian P, Wolfgang K. Occipital stroke shortly after cannabis consumption. Clin Neurol Neurosurg. 2004;106:305-308.
54. Beaconsfield P. Some cardiovascular effects of cannabis. Am Heart J. 1974;87:143-146.
55. Benowitz NL, Jones RT. Cardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestion. Clin Pharmacol Ther. 1975;18:287-297.
56. White D, Martin D, Geller T, et al. Stroke associated with marijuana abuse. Pediatr Neurosurg. 2000;32:92-94.
57. Geller T, Loftis L, Brink DS. Cerebellar infarction in adolescent males associated with acute marijuana use. Pediatrics. 2004;113:e365-e370.
58. Barnes D, Palace J, O'Brien MD. Stroke following marijuana smoking. Stroke. 1992;23:1381.
59. Zachariah SB. Stroke after heavy marijuana smoking. Stroke. 1991;22:406-409.
60. Tunving K, Thulin SO, Risberg J, et al. Regional cerebral blood flow in long-term heavy cannabis use. Psychiatry Res. 1986;17:15-21.
61. Herning RI, Better WE, Tate K, et al. Marijuana abusers are at increased risk for stroke. Preliminary evidence from cerebrovascular perfusion data. Ann N Y Acad Sci. 2001;939:413-415.
62. Mathew RJ, Wilson WH, Humphreys D, et al. Middle cerebral artery velocity during upright posture after marijuana smoking. Acta Psychiatr Scand. 1992;86:173-178.
63. Chang L, Ernst T, Grob CS, et al. Cerebral (1)H MRS alterations in recreational 3, 4-methylenedioxymethamphetamine (MDMA, "ecstasy") users. J Magn Reson Imaging. 1999;10:521-526.
64. Reneman L, Habraken JB, Majoie CB, et al. MDMA ("Ecstasy") and its association with cerebrovascular accidents: preliminary findings. AJNR Am J Neuroradiol. 2000;21:1001-1007.
65. Cowan RL, Lyoo IK, Sung SM, et al. Reduced cortical gray matter density in human MDMA (Ecstasy) users: a voxel-based morphometry study. Drug Alcohol Depend. 2003;72:225-235.
66. Gough B, Ali SF, Slikker W Jr, et al. Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoamines in rat caudate. Pharmacol Biochem Behav. 1991;39:619-623.
67. Green AR, Mechan AO, Elliott JM, et al. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev. 2003;55:463-508.
68. Mechan AO, Esteban B, O'Shea E, et al. The pharmacology of the acute hyperthermic response that follows administration of 3,4- methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats. Br J Pharmacol. 2002;135:170-180.
69. Yamamoto BK, Nash JF, Gudelsky GA. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra. J Pharmacol Exp Ther. 1995;273:1063-1070.
70. Spatt J, Glawar B, Mamoli B. A pure amnestic syndrome after MDMA ("ecstasy") ingestion. J Neurol Neurosurg Psychiatry. 1997;62:418-419.
71. Squier MV, Jalloh S, Hilton-Jones D, et al. Death after ecstasy ingestion: neuropathological findings. J Neurol Neurosurg Psychiatry. 1995;58:756.
72. Henry JA, Jeffreys KJ, Dawling S. Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy"). Lancet. 1992;340:384-387.
73. Chang L, Grob CS, Ernst T, et al. Effect of ecstasy [3,4- methylenedioxymethamphetamine (MDMA)] on cerebral blood flow: a co-registered SPECT and MRI study. Psychiatry Res. 2000;98:15-28.
74. Auer J, Berent R, Weber T, et al. Subarachnoid haemorrhage with "Ecstasy" abuse in a young adult. Neurol Sci. 2002;23:199-201.
75. McEvoy AW, Kitchen ND, Thomas DG. Intracerebral haemorrhage and drug abuse in young adults. Br J Neurosurg. 2000;14:449-454.